Novel, potent, selective, and orally bioavailable human βII-tryptase inhibitors

被引:11
|
作者
Sperandio, David [1 ]
Tai, Vincent W. -F. [1 ]
Lohman, Julia [1 ]
Hirschbein, Bernie [1 ]
Mendonca, Rohan [1 ]
Lee, Chang-Sun [1 ]
Spencer, Jeffrey R. [1 ]
Janc, James [1 ]
Nguyen, Margaret [1 ]
Beltman, Jerlyn [1 ]
Sprengeler, Paul [1 ]
Scheerens, Heleen [1 ]
Lin, Tong [1 ]
Liu, Liang [1 ]
Gadre, Ashwini [1 ]
Kellogg, Alisha [1 ]
Green, Michael J. [1 ]
McGrath, Mary E. [1 ]
机构
[1] Celera Gen, San Francisco, CA 94080 USA
关键词
D O I
10.1016/j.bmcl.2006.04.088
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis of novel [1,2,4]oxadiazoles and their structure-activity relationship (SAR) for the inhibition of tryptase and related serine proteases is presented. Elaboration of the P'-side afforded potent, selective, and orally bioavailable tryptase inhibitors. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4085 / 4089
页数:5
相关论文
共 50 条
  • [21] Design and evaluation of dihydroisoquinolines as potent and orally bioavailable human cytomegalovirus inhibitors
    Chan, L
    Stefanac, T
    Turcotte, N
    Hu, ZH
    Chen, YM
    Bédard, J
    May, S
    Jin, HL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (13) : 1477 - 1480
  • [22] Discovery of Pyridinyl Acetamide Derivatives as Potent, Selective, and Orally Bioavailable Porcupine Inhibitors
    Cheng, Dai
    Liu, Jun
    Han, Dong
    Zhang, Guobao
    Gao, Wenqi
    Hsieh, Mindy H.
    Ng, Nicholas
    Kasibhatla, Shailaja
    Tompkins, Celin
    Li, Jie
    Steffy, Auzon
    Sun, Fangxian
    Li, Chun
    Seidel, H. Martin
    Harris, Jennifer L.
    Pan, Shifeng
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (07): : 676 - 680
  • [23] Identification of Monosaccharide Derivatives as Potent, Selective, and Orally Bioavailable Inhibitors of Human and Mouse Galectin-3
    Liu, Chunjian
    Jalagam, Prasada Rao
    Feng, Jianxin
    Wang, Wei
    Raja, Thiruvenkadam
    Sura, Mallikarjuna Reddy
    Manepalli, Raju K. V. L. P.
    Aliphedi, Bheema Reddy
    Medavarapu, Santosh
    Muthalagu, Vetrichelvan
    Natesan, Ramesh
    Gupta, Anuradha
    Beno, Brett
    Panda, Manoranjan
    Ghosh, Kaushik
    Shukla, Jinal Kaushikkumar
    Sale, Harinath
    Haldar, Priyanka
    Kalidindi, Narasimharaju
    Shah, Devang
    Patel, Dipal
    Mathur, Arvind
    Ellsworth, Bruce A.
    Cheng, Dong
    Regueiro-Ren, Alicia
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (16) : 11084 - 11099
  • [24] Design of potent and highly selective inhibitors of human tryptase.
    Slusarchyk, WA
    Bisacchi, GS
    Hartl, KS
    Huang, MH
    Jacobs, G
    Ogletree, ML
    Sutton, J
    Treuner, U
    Zhao, GH
    Zahler, R
    Seiler, SM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U44 - U44
  • [25] Discovery of a novel, selective, and orally bioavailable class of aggrecanase inhibitors.
    Yao, WQ
    Chao, M
    Reddy, G
    Shi, E
    Arner, EC
    Pratta, MA
    Covington, MB
    Tortorella, MD
    Magolda, RL
    Wasserman, ZR
    Wexler, RR
    Decicco, CP
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U566 - U566
  • [26] Discovery of potent, selective, orally bioavailable Stearoyl-CoA desaturase 1 inhibitors
    Liu, Gang
    Lynch, John K.
    Freeman, Jennifer
    Liu, Bo
    Xin, Zhili
    Zhao, Hongyu
    Serby, Michael D.
    Kym, Philip R.
    Suhar, Tom S.
    Smith, Harriet T.
    Cao, Ning
    Yang, Ruojing
    Janis, Rich S.
    Krauser, Joel A.
    Cepa, Steven P.
    Beno, David W. A.
    Sham, Hing L.
    Collins, Christine A.
    Surowy, Teresa K.
    Camp, Heidi S.
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (13) : 3086 - 3100
  • [27] Potent, selective, and orally bioavailable matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis
    Hu, YH
    Xiang, JS
    DiGrandi, MJ
    Du, XM
    Ipek, M
    Laakso, LM
    Li, JC
    Li, W
    Rush, TS
    Schmid, J
    Skotnicki, JS
    Tam, S
    Thomason, JR
    Wang, Q
    Levin, JI
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (24) : 6629 - 6644
  • [28] Design and synthesis of potent, selective, and orally bioavailable macrocyclic TF-FVIIa inhibitors
    Zhang, Xiaojun
    Jiang, Wen
    Jacutin-Porte, Swanee
    Glunz, Peter W.
    Ladziata, Vladimir
    Zou, Yan
    Cheng, Xuhong
    Nirschl, Alexandra H.
    Johnson, James A.
    Philips, Monique
    Wurtz, Nicholas R.
    Parkhurst, Brandon L.
    Delucca, Indawati
    Luettgen, Joseph M.
    Knabb, Robert
    Rendina, Alan R.
    Harper, Timothy M.
    Wei, Anzhi
    Mueller, Luciano
    Cheney, Daniel L.
    Seiffert, Dietmar
    Wong, Pancras C.
    Wexler, Ruth R.
    Priestley, Scott
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [29] Potent, selective and orally bioavailable matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis
    Hu, Yonghan
    DiGrandi, Martin J.
    Du, Xuemei
    Ipek, Manus
    Laakso, Leif M.
    Li, Jianchang
    Li, Wei
    Rush, Thomas S.
    Schmid, Jean
    Skotnicki, Jerauld S.
    Tam, Steve
    Thomason, Jennifer R.
    Xiang, Jason S.
    Wang, Qin
    Levin, Jeremy I.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2665 - U2666
  • [30] Discovery of potent, highly selective, and orally bioavailable factor XIa inhibitors for anticoagulant therapy
    Zhang, Yajing
    Huang, Rong
    Hu, Xueqin
    Zheng, Nan
    Geng, Lei
    Yin, Zequn
    Duan, Yajun
    Wang, Qin
    Liao, Chenzhong
    Yang, Xiaoxiao
    Xie, Zhouling
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 289